Procter & Gamble
PG NYSE Personal Care Products Financials FY2017–FY2026
Procter & Gamble's revenue rose 3.3% to $87.0 billion in fiscal 2026. Its operating margin was 22.7%, down from 24.3% a year earlier. Free cash flow was $15.1 billion, up 7.8%. It paid out $15.3 billion in dividends and buybacks, 101% of free cash flow. The diluted share count fell 1.3%.
What Procter & Gamble does
Procter & Gamble makes everyday household and personal care products sold in about 180 countries and territories. Its brands include Tide, Downy, Dawn, Swiffer, Pampers, Always, Charmin, Bounty, Gillette, Crest, Oral-B, Vicks, Pantene, Head & Shoulders, Olay and Old Spice. Its net sales were $87.0 billion in the year to June 2026.
P&G reports five segments. Fabric & Home Care, which includes laundry detergent, dish soap and cleaning products, brought in 35% of net sales. Baby, Feminine & Family Care, with diapers, pads, paper towels and toilet paper, brought in 24%. Beauty, with shampoo, deodorant and skin care, brought in 19%; Health Care, with toothpaste, toothbrushes and cold and stomach remedies, 14%; and Grooming, mainly razors, 8%. It sells to big-box chains, online retailers, grocery, club and drug stores, and distributors, and sales to Walmart and its affiliates made up about 16% of total sales. P&G says it competes with companies large and small, including global brands and stores' own private-label products.
P&G had about 104,000 employees at the end of June 2026, down from the year before because of a restructuring program, and operations in about 65 countries. It buys almost all its raw and packaging materials from outside suppliers, some of them the only source for an item.
- Legal name
- PROCTER & GAMBLE CO
- Fiscal year ends
- June 30, 2026
- Latest annual report
- 10-K · Aug 4, 2026
- Accession · CIK
- 0000080424-26-000103
0000080424
Revenue and margins
Procter & Gamble had $87.0B of revenue in fiscal 2026, up 3.3% on the year before.
Net income and earnings per share
From fiscal 2017 to 2026, diluted EPS grew 1.9% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $15.1B in fiscal 2026, 17.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Procter & Gamble returned $15.3B to shareholders in fiscal 2026, 101% of free cash flow. The diluted share count fell 1.3%.
Value Procter & Gamble yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.
Discounted cash flow
Value per share
—
Adds net cash of −$24.2B and divides by 2,422.5M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
—
Reference multiples: today 24.3x · peers 68.4x · sector 24.6x.
Balance sheet
Cash, debt and the ratios that show how comfortably Procter & Gamble can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $7.2B | $8.2B | $9.5B | $9.6B | $9.9B |
| Debt incl. finance leases | $31.3B | $34.6B | $32.4B | $34.5B | $34.1B |
| Net debt / EBITDA | 1.2x | 1.3x | 1.1x | 1.1x | 1.1x |
| Debt / equity | 0.7x | 0.7x | 0.6x | 0.7x | 0.6x |
| Interest coverage | 40.6x | 24.0x | 20.1x | 22.6x | 22.5x |
| Current ratio | 0.7x | 0.6x | 0.7x | 0.7x | 0.7x |
| Quick ratio | 0.5x | 0.4x | 0.5x | 0.5x | 0.5x |
| Total assets | $117.2B | $120.8B | $122.4B | $125.2B | $126.5B |
| Total liabilities | $70.4B | $73.8B | $71.8B | $72.9B | $72.2B |
| Shareholders' equity | $46.9B | $47.1B | $50.6B | $52.3B | $54.3B |
| Net debt (− = net cash) | $24.1B | $26.3B | $23.0B | $24.9B | $24.2B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$5.5M
9 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 5, 2026 | Andre SchultenChief Financial Officer | Sold | 3,914 | $145.34 | $0.6M | Form 4 |
| Oct 5, 2026 | Paul GamaCEO- Health Care | Sold | 2,225 | $145.34 | $0.3M | Form 4 |
| Oct 5, 2026 | Susan Street WhaleyChief Legal Officer & Secy | Sold | 2,369 | $145.34 | $0.3M | Form 4 |
| Aug 24, 2026 | Matthew W. JanzarukSVP - Chief Accounting Officer | Sold | 359 | $145.24 | $0.1M | Form 4 |
| Aug 21, 2026 | Sundar G. RamanCEO-Fabric Home & Habitat Care | Sold | 3,435 | $143.02 | $0.5M | Form 4 |
| Aug 20, 2026 | Andre SchultenChief Financial Officer | Sold | 5,402 | $143.79 | $0.8M | Form 4 |
| Aug 20, 2026 | Balaji PurushothamanChief Human Resources Officer | Sold | 2,019 | $143.79 | $0.3M | Form 4 |
| Aug 20, 2026 | de Azevedo Juliana Monteiro SantosCEO - Grooming | Sold | 2,368 | $143.79 | $0.3M | Form 4 |
| Aug 20, 2026 | Marc S. PritchardChief Brand Officer | Sold | 4,030 | $143.79 | $0.6M | Form 4 |
| Aug 20, 2026 | Paul GamaCEO- Health Care | Sold | 3,396 | $143.79 | $0.5M | Form 4 |
| Aug 20, 2026 | Shailesh JejurikarChairman, President and CEO, Director | Sold | 6,176 | $143.79 | $0.9M | Form 4 |
| Aug 20, 2026 | Susan Street WhaleyChief Legal Officer & Secy | Sold | 2,238 | $143.79 | $0.3M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ |
| Return on assets rose | ✕ | ✓ | ✕ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ |
| Debt fell relative to assets | ✓ | ✕ | ✓ |
| Current ratio rose | ✓ | ✕ | ✕ |
| Share count didn't rise | ✓ | ✓ | ✓ |
| Gross margin rose | ✓ | ✕ | ✕ |
| Revenue rose relative to assets | ✕ | ✕ | ✓ |
| F-score | 7 / 9 | 5 / 9 | 6 / 9 |
| Accruals ratio | −4.1% | −1.5% | −2.8% |
| Altman Z'' | 4.58 | 4.67 | 4.69 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Procter & Gamble PG | $387.6B | 3.3% | 22.7% | 17.4% | 20.1% | 24.3x | 6 | |
| Kenvue KVUE | $37.6B | −2.1% | 16.0% | 11.4% | 10.0% | 22.5x | 6 | Compare → |
| Estée Lauder Companies EL | $39.6B | 5.1% | 5.2% | 8.7% | 4.9% | — | 6 | Compare → |
| Coty COTY | $2.8B | −1.5% | −1.4% | 6.0% | −1.0% | — | 3 | Compare → |
| e.l.f. Beauty ELF | $6.8B | 24.6% | 4.5% | 11.6% | 3.8% | 114.2x | 4 | Compare → |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $65.1B | $66.8B | $67.7B | $71.0B | $76.1B | $80.2B | $82.0B | $84.0B | $84.3B | $87.0B |
| Gross profit | $32.4B | $32.4B | $32.9B | $35.7B | $39.0B | $38.0B | $39.2B | $43.2B | $43.1B | $43.7B |
| Research and development | $1.9B | $1.9B | $1.9B | $1.8B | $1.9B | $2.0B | $2.0B | $2.0B | $2.1B | $2.1B |
| Operating income | $13.8B | $13.4B | $5.5B | $15.7B | $18.0B | $17.8B | $18.1B | $18.5B | $20.5B | $19.7B |
| Interest expense | $465M | $506M | $509M | $465M | $502M | $439M | $756M | $925M | $907M | $877M |
| Pretax income | $13.3B | $13.3B | $6.1B | $15.8B | $17.6B | $18.0B | $18.4B | $18.8B | $20.2B | $20.4B |
| Income tax | $3.1B | $3.5B | $2.1B | $2.7B | $3.3B | $3.2B | $3.6B | $3.8B | $4.1B | $4.2B |
| Net income | $15.3B | $9.8B | $3.9B | $13.0B | $14.3B | $14.7B | $14.7B | $14.9B | $16.0B | $16.0B |
| Diluted EPS | $5.59 | $3.67 | $1.43 | $4.96 | $5.50 | $5.81 | $5.90 | $6.02 | $6.51 | $6.62 |
| Diluted shares | 2.74B | 2.66B | 2.54B | 2.63B | 2.60B | 2.54B | 2.48B | 2.47B | 2.45B | 2.42B |
| Cash flow | ||||||||||
| Cash from operations | $12.8B | $14.9B | $15.2B | $17.4B | $18.4B | $16.7B | $16.8B | $19.8B | $17.8B | $19.6B |
| Capital expenditure | $3.4B | $3.7B | $3.3B | $3.1B | $2.8B | $3.2B | $3.1B | $3.3B | $3.8B | $4.4B |
| Free cash flow | $9.4B | $11.2B | $11.9B | $14.3B | $15.6B | $13.6B | $13.8B | $16.5B | $14.0B | $15.1B |
| Depreciation and amortization | $2.8B | $2.8B | $2.8B | $3.0B | $2.7B | $2.8B | $2.7B | $2.9B | $2.8B | $3.2B |
| Stock-based compensation | $351M | $395M | $515M | $558M | $540M | $528M | $545M | $562M | $476M | $524M |
| Acquisitions | $16.0M | $109M | $3.9B | $58.0M | $34.0M | $1.4B | $765M | $21.0M | $11.0M | $85.0M |
| Share buybacks | $5.2B | $7.0B | $5.0B | $7.4B | $11.0B | $10.0B | $7.4B | $5.0B | $6.5B | $5.0B |
| Dividends paid | $7.2B | $7.3B | $7.5B | $7.8B | $8.3B | $8.8B | $9.0B | $9.3B | $9.9B | $10.2B |
| Dividends and buybacks | $12.4B | $14.3B | $12.5B | $15.2B | $19.3B | $18.8B | $16.4B | $14.3B | $16.4B | $15.3B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $5.6B | $2.6B | $4.2B | $16.2B | $10.3B | $7.2B | $8.2B | $9.5B | $9.6B | $9.9B |
| Total debt | $31.4B | $30.4B | $30.0B | $34.6B | $31.9B | $31.3B | $34.6B | $32.4B | $34.5B | $34.1B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $26.5B | $23.3B | $22.5B | $28.0B | $23.1B | $21.7B | $22.6B | $24.7B | $25.4B | $26.2B |
| Current liabilities | $30.2B | $28.2B | $30.0B | $33.0B | $33.1B | $33.1B | $35.8B | $33.6B | $36.1B | $38.7B |
| Inventory | $4.6B | $4.7B | $5.0B | $5.5B | $6.0B | $6.9B | $7.1B | $7.0B | $7.6B | $8.2B |
| Property and equipment, net | $19.9B | $20.6B | $21.3B | $20.7B | $21.7B | $21.2B | $21.9B | $22.2B | $23.9B | $25.4B |
| Total assets | $120.4B | $118.3B | $115.1B | $120.7B | $119.3B | $117.2B | $120.8B | $122.4B | $125.2B | $126.5B |
| Total liabilities | $64.6B | $65.4B | $67.5B | $73.8B | $72.7B | $70.4B | $73.8B | $71.8B | $72.9B | $72.2B |
| Shareholders' equity | $55.8B | $52.9B | $47.6B | $46.9B | $46.7B | $46.9B | $47.1B | $50.6B | $52.3B | $54.3B |
| Margins | ||||||||||
| Gross margin | 49.8% | 48.5% | 48.6% | 50.3% | 51.3% | 47.4% | 47.9% | 51.4% | 51.2% | 50.2% |
| Operating margin | 21.2% | 20.0% | 8.1% | 22.1% | 23.6% | 22.2% | 22.1% | 22.1% | 24.3% | 22.7% |
| EBITDA margin | 25.5% | 24.2% | 12.3% | 26.4% | 27.2% | 25.7% | 25.4% | 25.5% | 27.6% | 26.3% |
| Net margin | 23.6% | 14.6% | 5.8% | 18.4% | 18.8% | 18.4% | 17.9% | 17.7% | 19.0% | 18.4% |
| FCF margin | 14.4% | 16.7% | 17.6% | 20.2% | 20.5% | 16.9% | 16.8% | 19.7% | 16.7% | 17.4% |
| Returns | ||||||||||
| Return on capital | 13.1% | 12.2% | 4.7% | 18.7% | 21.9% | 21.0% | 20.2% | 20.2% | 21.6% | 20.1% |
| Return on capital employed | 14.8% | 14.8% | 6.3% | 18.2% | 20.7% | 20.9% | 21.4% | 21.3% | 23.0% | 22.3% |
| Return on equity | 26.9% | 18.0% | 7.8% | 27.6% | 30.6% | 31.5% | 31.2% | 30.5% | 31.1% | 30.1% |
| Return on assets | 12.4% | 8.2% | 3.3% | 11.1% | 11.9% | 12.5% | 12.3% | 12.2% | 12.9% | 12.8% |
| Growth | ||||||||||
| Revenue growth | −0.4% | 2.7% | 1.3% | 4.8% | 7.3% | 5.4% | 2.3% | 2.5% | 0.3% | 3.3% |
| Net income growth | 45.9% | −36.4% | −60.0% | 234.3% | 9.8% | 3.1% | −0.6% | 1.5% | 7.4% | 0.5% |
| EPS growth | 51.5% | −34.4% | −61.0% | 246.9% | 10.9% | 5.6% | 1.6% | 2.0% | 8.1% | 1.7% |
| FCF growth | −22.7% | 19.0% | 6.7% | 20.5% | 8.8% | −12.9% | 1.6% | 19.9% | −15.0% | 7.9% |
| Share count change | −3.7% | −3.1% | −4.4% | 3.4% | −0.9% | −2.4% | −2.2% | −0.5% | −0.7% | −1.3% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.6x | 1.7x | 3.1x | 1.0x | 1.0x | 1.2x | 1.3x | 1.1x | 1.1x | 1.1x |
| Debt / equity | 0.6x | 0.6x | 0.6x | 0.7x | 0.7x | 0.7x | 0.7x | 0.6x | 0.7x | 0.6x |
| Interest coverage | 29.6x | 26.4x | 10.8x | 33.8x | 35.8x | 40.6x | 24.0x | 20.1x | 22.6x | 22.5x |
| Current ratio | 0.9x | 0.8x | 0.8x | 0.9x | 0.7x | 0.7x | 0.6x | 0.7x | 0.7x | 0.7x |
| Quick ratio | 0.7x | 0.7x | 0.6x | 0.7x | 0.5x | 0.5x | 0.4x | 0.5x | 0.5x | 0.5x |
| Capital allocation | ||||||||||
| Capex / revenue | 5.2% | 5.6% | 5.0% | 4.3% | 3.7% | 3.9% | 3.7% | 4.0% | 4.5% | 5.1% |
| Stock comp / revenue | 0.5% | 0.6% | 0.8% | 0.8% | 0.7% | 0.7% | 0.7% | 0.7% | 0.6% | 0.6% |
| Payouts / FCF | 132.8% | 128.4% | 105.1% | 106.0% | 123.7% | 138.4% | 118.6% | 86.7% | 116.6% | 100.8% |
| Quality scores | ||||||||||
| Piotroski F-score | 6.0 | 5.0 | 6.0 | 7.0 | 8.0 | 7.0 | 7.0 | 7.0 | 5.0 | 6.0 |
| Altman Z'' | 4.1 | 4.1 | 3.3 | 4.0 | 4.0 | 4.2 | 4.2 | 4.6 | 4.7 | 4.7 |
| Accruals ratio | 2.1% | −4.3% | −9.7% | −3.7% | −3.4% | −1.7% | −1.8% | −4.1% | −1.5% | −2.8% |
Source: SEC EDGAR XBRL filings (CIK 0000080424). Data updated October 22, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.